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Abstract 
Sickle cell trait (SCT) occurs in about 8% of
African-Americans and is often described to be
of little clinical consequence. Over time, a
number of risks have emerged, and among
these are rare but catastrophic episodes of
sudden death in athletes and other individuals
associated with physical activities which is
often described as exercise collapse associated
with sickle trait (ECAST). Despite an epidemi-
ologic link between SCT and sudden death as
well as numerous case reports in both medical
literature and lay press, no clear understand-
ing of the key pathophysiologic events has
been identified. Strategies for identification of
individuals at risk and prevention of ECAST
have been both elusive and controversial.
Stakeholders have advocated for different
approaches to this issue particularly with
regard to screening for hemoglobin S.
Furthermore, the recommendations and guide-
lines that are in place for the early recognition
of ECAST and the prevention and treatment of
the illness are not well defined and remain
fragmented. Among the cases identified, those
in collegiate football players in the United
States are often highlighted. This manuscript
examines these case studies and the current
recommendations to identify areas of consen-
sus and controversy regarding recommenda-
tions for prevention, recognition and treat-
ment of ECAST.
Introduction
Mutations in the alpha and beta globin
genes of hemoglobin (Hgb) frequently occur.
Among the most commonly encountered world-
wide is the β6Glu→Val substitution defining
Hgb S. In sickle cell disease both beta globin
genes are affected while in sickle cell trait
(SCT) one normal and one mutated beta glo-
bin gene result in a pancellular distribution of
Hgb S accounting for about 40% of the total
Hgb. A number of studies have found the
prevalence of SCT in the African-American
population to be about 7-8%, but it is also iden-
tified in persons of other ethnic backgrounds
at a lower frequency translating into about 3
million affected individuals in the United
States and 300 million worldwide.1 A study of
US military personnel similarly showed that
7.8% of black recruits had SCT suggesting that
there is no apparent selection against enroll-
ment in the military service.2 The incidence of
SCT in athletes is not well defined although its
prevalence in black football players in the
National Football League was 39/579 (6.7%)
similar to that in the general population.3
Studies on the physiologic effects of exer-
tion have long established that exercise can
induce a metabolic acidosis.4,5 Notable among
these studies is the observation that repeat
exertion to exhaustion can lead to extreme
acidosis, and this exercise pattern is similar to
some currently used regimens of athletic train-
ing.4 In patients with sickle cell disease, trig-
gers for vaso-occlusion include acidosis, dehy-
dration and hypoxia, raising the suspicion that
extreme exertion may be sufficient under cer-
tain circumstances to trigger similar complica-
tions in individuals with SCT. Additional in
vitro data indicates that red blood cells (RBCs)
from SCT individuals may become irreversibly
sickled at a PO2 of ~25 mmHg, and this effect
is enhanced by acidosis.6 This is confirmed by
studies in SCT individuals that showed venous
sickling at low oxygen tension.7 Subsequently
a small study comparing individuals with and
without SCT who underwent intensive exer-
cise showed that a small percentage of irre-
versibly sickled cells could be identified in all
the individuals with SCT but none of those
without Hgb S.8 No untoward clinical effects
were identified, but this raises the concern
that under some conditions, extensive forma-
tion of irreversibly sickled cells may occur that
lead to clinical consequences. In addition to
hypoxia and acidosis, other conditions that
may trigger such events have also been sus-
pected including increased core body tempera-
ture, ambient heat index, blood viscosity, dehy-
dration, inflammation and oxidative stress, but
the relative role of each of these factors is not
fully defined.9-11 On the other hand, some stud-
ies have failed to show a clear physiologic
effect from SCT on exercise even under some
stressful conditions.12 The consequence has
been that when fatalities have occurred in
individuals with SCT, they are perceived as
rare and unpredictable events. However, in
1987, the seminal study by Kark and associates
found non-traumatic sudden death in black
military recruits to be 32 fold higher than in
individuals identified as non-black. Among
black recruits, the relative risk of sudden
unexplained death was 27.6 fold higher in the
individuals with SCT, thus providing clear epi-
demiologic evidence that the presence of Hgb
S contributed to these deaths.2 Harmon and
colleagues have also reported a 37-fold greater
risk of exertion-related death in Division 1 col-
lege football in individuals with SCT.13
Recently, a summit on SCT composed of mili-
tary, athletic and medical experts tried to iden-
tify clinical guidelines for this problem and
have termed these events as exercise collapse
associated with sickle trait (ECAST).14 The
purpose of this manuscript is to evaluate the
reported cases of sudden death in college foot-
ball players related to SCT and to examine cur-
rent recommendations for prevention and
treatment of ECAST.
Materials and Methods
Data searches were performed of both med-
ical literature and lay press to identify cases of
potential ECAST. Once cases were identified,
these were limited to lethal events within 48
hours among American college football players
from 2000-2010, for these patients had less vari-
ation in their physical fitness than the general
population. Physical data was collected includ-
ing age, height and weight. Circumstances sur-
rounding their deaths were noted, including
activities prior to the collapse and climate con-
ditions at the time of these events.
Recommendations regarding SCT among
professional organizations involved in either
hematology or sports medicine were identified
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as described in the most recent stances pub-
lished on their websites. Their positions on
universal screening for SCT were identified,
and their recommendations on prevention,
detection, and treatment of ECAST were also
recorded.
Results
Table 1 summarizes the SCT related deaths
that occurred in college football between 2000-
2010.15-24 While each case is unique, they
share many characteristics, such as the ath-
letes or their coaches encouraging the partici-
pants despite evolving symptoms of ECAST. All
occurred during intense conditioning includ-
ing serial sprints and/or agility training. Many
experienced unusual cramps, muscle weak-
ness, extreme fatigue, and even a first collapse
before slumping to the ground for their last
time. In one reported instance, the athlete was
reprimanded for his perceived weakness and
neglected by trainers, and a teammate was
rebuked for assisting him off the field.15
Additionally, these cases all occurred below an
elevation of 645 m above sea level, so high alti-
tude hypoxia is not necessary for ECAST to
occur.15-24 While conditions were warm and
humid in some cases, the weather alone was
not typical of that which places athletes at a
high risk for heat-related illness. While several
of the initial reports cited heat-related illness
or other causes as the primary reasons for
death, autopsies later revealed that sickle cells
were identified and likely contributed to the
athletes’ death. Although a personal or family
history of SCT was available in some cases, in
no case was SCT suspected as the cause of the
collapse, so there was no clear medical inter-
vention or focused treatment.
Table 2 shows the positions of various
health and sports organizations on screening,
prevention and treatment of SCT. While the
National Collegiate Athletic Association
(NCAA) mandates the universal screening of
its participants, the American Society of
Hematology (ASH) is unequivocally against
universal screening for SCT. Other organiza-
tions vary in their positions on screening and
prevention. In the absence of strong medical
evidence, these organizations provide differ-
ing recommendations on the prevention of
ECAST. The National Athletic Trainers’
Association (NATA) has made clear recom-
mendations on preventative measures, and
other organizations reference the NATA’s
guidelines.25 These recommendations include
longer rest and recovery between conditioning
repetitions, exclusion from performance tests,
hydration, and available supplemental O2.
Other organizations highlight similar themes
but vary in the details. While these guidelines
are directed at athletes with SCT, some organ-
izations, such as ASH, American Medical
Society for Sports Medicine (AMSSM), and
Sickle Cell Disease Association of America
(SCDAA), advise using similar recommenda-
tions as universal precautions concluding that
this would safeguard all athletes from heat-
related illness and other effects of overexer-
tion. Whether this approach will prove effec-
tive in preventing ECAST is not clear and
remains controversial.26 Other organizations
that agreed with ASH include the American
Public Health Association, Association of
Public Health Laboratories, American Society
of Clinical Pathology, and the American Society
of Pediatric Hematology-Oncology (ASPHO),
but none of these added any further recom-
mendations. In contrast, most sports organiza-
tions do not specify these guidelines for uni-
versal precautions by all athletes, favoring a
targeted approach. Few organizations provided
guidelines for detecting and treating a sick-
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Table 1. Cases of fatal, exercise collapse in college football players with sickle cell trait.
Ref. Patient Institution Altitude Year Ambient Activities prior to collapse Comments
Age height/weight (m above conditions
sea level) temperature (°F)
15 19 5’11”/190 lbs Tennessee Tech 350 2000 mid 80’s Collapsed during sprint testing Death initially felt
on first day of conditioning to be heat stroke
16 18 6’2”/220 lbs Florida State <60 2001 Indoors, <80 Collapsed indoors during offseason Death initially felt
intense agility (mat) drills, was suffering to be cardiac
from head cold at time of collapse arrhythmia
17 18 5’9”/190 lbs Bowling Green 167 2004 85-88 Collapsed with unusual leg cramps
while running serial sprints known as gassers
18 19 6’3”/220 lbs Missouri 230 2005 85 Poor performance about 45 min into Death initially
conditioning, complained of blurry vision attributed to viral
but was forced to repeat the drills meningitis
19 19 5’9”/190 lbs Rice 38 2006 Warm afternoon Struggled through conditioning, breathing
heavily and complaining of leg cramping,
collapsed after his sixteenth 100 m dash
20 19 5’10”/181 lbs Central Florida 29 2008 Indoors Second workout after spring break, struggled
through an obstacle course after completing
a weightlifting session, was breathing heavily
with muscle weakness, coach singled athlete
out for lack of effort, collapsed at end of practice
21,22 22 6’3”/260 lbs N. Carolina A&T 272 2008 Complained of dizziness after running sprints Death initially
for conditioning, loss of consciousness attributed to heat
in the training room after practice related illness
23 20 5’10”/185 lbs Western Carolina 645 2009 Complained of leg cramps during offseason Enlarged heart
conditioning drills, loss of consciousness in autopsy
24 20 5’9”/186 lbs Mississippi 154 2010 Collapsed after first agility drill but was 
encouraged to continue, collapsed after second 
station and was allowed to rest, prior to collapse
trainers began to provide aid, transported to the









[page 68]                                                            [Hematology Reports 2014; 6:5502]
ling-related collapse, but those who did gener-
ally support the NATA’s policy in these areas. 
DiscussionFatal exertional sickling
Sickle cell trait as a cause of sudden death
in athletes was first noted in 1974 with the
death of an American collegiate football
player.26 Since that time there have been a
number of widely publicized cases in the non-
scientific literature. Most of these have
involved college football players rather than
younger students or older professional ath-
letes, and the reasons for this are not clear
although the widespread public interest in col-
lege football may explain this in part. While fit-
ness levels could potentially affect the athlete’s
likelihood of ECAST since these deaths
occurred during pre-season conditioning,
these athletes were generally recognized to be
in excellent physical condition. Nevertheless,
improved conditioning may modulate several
biological factors, notably inflammation and
oxidative stress.10,11 In accord with the known
pathophysiology, it seems more likely that a
decrease in venous PO2 in concert with acido-
sis occurring during extreme exertion were
major contributors. While it is conceivable that
the presence of sickled RBCs occurred post-
mortem, the clear epidemiologic evidence link-
ing SCT to sudden death is a compelling argu-
ment for a direct causal effect.2,13
At present in the United States, it is likely
that almost all high school aged students and an
increasing number of older athletes have
already been tested for Hgb S as part of newborn
screening. Adopted as a guideline by the
National Institutes of Health for all individuals
in 1987, hemoglobinopathy testing became
incorporated into newborn screening programs
in all states by 2006, so sickle cell status should
be available for all children and adolescents
born after that time.27 Despite this, the preva-
lence of SCT in athletes participating in organ-
ized sports is generally unknown. In the case of
college football, ethnicity data collected on play-
ers in the NCAA over the span from 2000-2010
shows an increase in participation by African-
Americans from 16,200 participants (28.1%) to
22,892 (34.5%).28 Assuming a prevalence of SCT
of 7%, this would indicate that there are cur-
rently ~1600 athletes playing NCAA football who
are at risk. Based on the recent reported deaths
of about one athlete with SCT every 1-2 years
described in Table 1, this would suggest the
estimated risk of death from ECAST to be 26-
51/100,000/100,000 participants. By compari-
son, calculations for fatal traumatic injuries in
any college football player is 0.45/100,000 and
the risk for other non-traumatic death is
2.1/100,000.29 An analysis of all NCAA Division I
athletes in all sports estimated over 2,000 par-
ticipants with SCT and predicts about 7 deaths
over a 10 year period consistent with the cur-
rent review.30
Just as identifying the key pathophysiologic
triggers for ECAST has proven to be difficult,
determining the risk of SCT remains a vexing
problem. For example, if the prevalence of SCT
in football players is lower than in the general
population, then the relative risk would be sig-
nificantly higher than estimated. In addition, if
other non-fatal complications such as heat
stroke can be attributed at least in part to SCT,
then serious but non-fatal complications could
be significantly higher than assumed. On the
other hand, if deaths attributed to SCT are
overestimated, then the relative risk may be
lower. Better defining the population at risk for
ECAST and other sickle cell related complica-
tions by identifying individuals with Hgb S
would seem to be a prerequisite to studying
the natural history and clinical consequences
of SCT. According to ClinicalTrials.gov, at least
one such effort along these lines is underway
by collecting self-reported health data in cur-
rent or former high school or college football
players with SCT.31Screening, prevention and treatment
In the absence of a clear understanding of
both the inciting pathophysiology and the iden-
tification of individuals at risk of ECAST, a num-
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Table 2. Summary of guidelines for sickle cell trait screening and prevention, detection, and treatment of exertional sickling.
Organization Sickle cell trait screening Recommendations for prevention
National Collegiate Athletic Mandate universal screening Similar to NATA recommendations
Association in all sports to participate
National Athletic Trainers Supports universal screening Set their own pace; increase intensity in a paced progression, and rest longer
Association21 between repetitions; participate in preseason conditioning; programs;
be excluded from certain tests such as mile runs and serial sprints; stop activity when
experiencing symptoms of rhabdomyolysis; do not exercise if ill; adjust activity
accordingly in extreme heat, at altitude, with dehydration, and with asthma;
be able to recognize symptoms of sickling
American College of Sports Supports universal screening; Encourages team physicians and athletic trainers to become familiar with
Medicine (ACSM) Genetic counseling for abnormal results SCT concerns and symptoms of sickling; Shouldn’t be restricted from activity
American Medical Society Approves NCAA’s policy Supports ASH in pursuit of universal precautions that make sports safer for all
for Sports Medicine (AMSSM)
College of American Supports universal screening Take precautions similar to those recommended by NATA
Pathologists (CAP)
American Society of Against universal screening Recommends use of universal precautions
Hematology (ASH)
Sickle Cell Disease Association Promotes voluntary screening, Implement universal precautions
of America (SCDAA) but is against universal screening
National Federation of State Recommended, not required See NATA consensus statement
High School Associations (NFHS)
American Orthopedic Society Recommended, not required See NATA consensus statement
of Sports Medicine (AOSSM)
Centers for Disease Control No recommendations Set their own pace; rest often between rounds in drills;
(CDC) stay hydrated throughout exercise; avoid overheating by misting athletes
with water or going into air conditioning during breaks; promptly seek medical
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ber of organizations involved in the direct care
of athletes and military service personnel have
provided guidelines on the screening for SCT
and, in a few cases, recommendations for pre-
vention, recognition, and treatment of ECAST
(Table 2). Most contentious among these recom-
mendations has been whether or not to employ
universal screening to identify individuals with
SCT. A number of organizations have advocated
for universal screening, and most notably the
NCAA has incrementally implemented universal
sickle cell screening by mandating either cur-
rent testing, evidence of previous testing, or a
signed waiver deferring legal liability for ath-
letes to participate. This policy was initiated to
identify participants at risk so that coaches,
trainers and staff are aware of these individuals
and can implement preventative measures and
early treatment against ECAST. Additionally, this
policy was driven in part by the litigation that
arose from the unexpected death of an individ-
ual who was unaware of his sickle cell status.19
When the NCAA policy was implemented, a sur-
vey indicated that only about 22% of responding
institutions screened all athletes, but this is like-
ly to have increased significantly over time.32 In
contrast to the NCAA, ASH set forth a position
paper in 2012 outlining the case against univer-
sal screening, including the maintenance of pri-
vacy of personal health information for those
athletes. Arguments against universal screening
are numerous and have been highlighted by
Bonham et al.33 These include the cost and reli-
ability of testing. However, screening can be
completed with one of several commercially
available blood tests at a cost of $3.00-4.00/sam-
ple with high reliability, and additional confir-
matory testing such as high performance liquid
chromatography (HPLC) analysis could be
offered to individuals identified to have a sick-
ling Hgb. Another concern is whether the knowl-
edge of SCT status will jeopardize the playing
career or lead to prejudicial judgments regard-
ing participation in any activity. This has been
noted in the past when SCT individuals were
excluded from certain military occupations.34
More recently, we identified scant evidence that
military personnel or competitive athletes who
have SCT are excluded from their respective
activities. Some organizations remain con-
cerned that screening would violate the athlete’s
privacy and lead to discrimination.33 Other ongo-
ing concerns regarding a universal screening
policy include a lack of genetic counseling for
affected individuals. Furthermore, while the US
Army has abolished universal screening in favor
of universal precautions, the US Marine Corps
continues to test all recruits.35
Less often discussed but of considerable
importance are specific recommendations for
prevention, detection, and treatment of ECAST.
Recommendations for prevention have been
made by a number of organizations and have
common themes although vary in their details.
Whether universal precautions against sick-
ling for all participants or some form of target-
ed prevention for individuals with confirmed
SCT is the most effective is not defined. The
NATA published a consensus statement with
recommendations regarding prevention of
sudden death in sports, especially with envi-
ronmental stress.25 Of note, NATA has suggest-
ed a framework to distinguish between a sick-
ling-related collapse and other diagnoses so
that athletes and staff could recognize the
issue and respond to it appropriately. The
SCDAA, AOSSM, NFHS, and NCAA have refer-
enced NATA’s information on the detection of
ECAST. Additionally, Eichner has recently
described features of a SCT associated collapse
along with prevention and treatment sugges-
tions.36 Based on the anecdotal data, it seems
reasonable that all coaches, trainers and play-
ers involved in sports at risk should be familiar
with prevention guidelines and their potential
for implementation. By increasing staff and
player education about SCT, it is reasonable to
conclude that most cases of ECAST and its con-
sequences are preventable.
Optimal treatment of ECAST is undefined
and is usually a medical emergency that falls to
first responders rather than to hematologists
or others with expertise in sickle cell disease.
Only a few organizations have published treat-
ment recommendations, and there are no well-
designed studies in the medical literature
describing successful (or unsuccessful)
approaches. While many organizations have
overlapping ideas on how to manage ECAST,
their suggestions and opinions vary and fail to
provide consistent advice for those caring for
athletes or others who might be at risk. No
approach has been tested in a clinical study.
Rare cases have been reported in which ath-
letes initially diagnosed with heat stroke were
subsequently identified as having ECAST and
recovered.37 Among the organizations provid-
ing recommendations regarding ECAST, one
common theme arises: athletes and military
personnel should not be barred or limited in
opportunities because they have SCT. Since
these organizations all support the success of
athletes with SCT, an agreed upon set of guide-
lines for coaches, trainers, athletes and med-
ical personnel to follow in order to maintain
player safety should be a priority.
While the issue of ECAST has been raised
most frequently in the setting of military serv-
ice and competitive athletics, sudden death in
individuals with SCT has been noted in other
circumstances of strenuous activity including
firefighter training and altercations with law
enforcement.38 While screening and preven-
tion may be possible in some of these circum-
stances, this may not always be the case, and
rapid recognition of the illness and proper
emergent treatment remain key issues.
We believe that the lack of a consensus on
the approach to ECAST poses an opportunity
for additional research in both the understand-
ing of the pathophysiology and of the risks
linked to SCT, as well as the clinical approach
to prevention, diagnosis and treatment of
ECAST. The lack of understanding of who may
be at risk hinders further clinical studies, so
screening for research purposes could prove
beneficial. Whether or not milder forms of clin-
ically significant ECAST exist and are prevent-
able or treatable might become apparent and,
if present, may also lead to the identification of
biomarkers for people at risk. The possible
relationship to heat-related illness, rhabdomy-
olysis, and other abnormalities such as glu-
cose-6-phosphate dehydrogenase (G6PD) defi-
ciency remains to be defined. Furthermore, a
well-conceived approach to ECAST including
recognition and treatment in other settings
beyond the military and athletics needs to be
delineated. 
Conclusions
Compared to some other medical subspecial-
ties, the role of the hematologist in sports med-
icine has been modest. In addition to the under-
standing of ECAST in competitive athletics, it is
also important for hematologists to take a lead-
ership role in other areas of sports medicine in
which hematologic issues arise. Examples of
these include the study of the risk, prevention
and treatment of bleeding in casual or competi-
tive athletes with hemophilia or on anticoagu-
lants and the study of the role of iron supple-
mentation in optimizing athletic performance.
This, along with determining guidelines for the
prevention, detection, and treatment of ECAST,
allows more athletes to participate safely in
sports without otherwise benign blood condi-
tions hindering their participation.
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